Last reviewed · How we verify
NCT06247072
TRK-3 Conformance to Standards for Tonometers
trial testing Tonometer in Glaucoma in 125 participants. Completed in 4 April 2024.
4 April 2024
Quick facts
| Lead sponsor | Topcon Corporation |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 125 |
| Start date | 2 February 2024 |
| Primary completion | 4 April 2024 |
| Estimated completion | 4 April 2024 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Tonometer
Conditions studied
- Glaucoma — all drugs for Glaucoma →
Sponsor
Topcon Corporation
Who can join
22 and older, any sex, with Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To collect measurements of a new tonometer and show conformance to standards for tonometers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06247072
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Tonometer
Trials testing the same drug.
- NCT00570791 — Effect of Central Corneal Thickness On IOP Using Various Tonometers · completed
Other recruiting trials for Glaucoma
Currently open trials in the same condition.
- NCT07455786 — Modified Trabeculectomy After Failure of Combined Phaco With GATT · NA · recruiting
- NCT07298356 — Automated Applanation Tonometry - Updated · NA · recruiting
- NCT07217678 — Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use · Phase 4 · recruiting
- NCT07145073 — Repetitive Transcranial Alternating Current Stimulation (rtACS) for the Treatment of Optic Neuropathies · NA · recruiting
- NCT07209410 — Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanopro · Phase 4 · recruiting
Other Topcon Corporation trials
Trials by the same sponsor.
- NCT06733428 — Agreement and Precision Study · completed
- NCT06250868 — TRK-3 Performance of Pachymetry · completed
- NCT06135727 — Screening Protocol · terminated
- NCT05286502 — NW500 Non-Mydriatic Retinal Camera Clinical Performance Study · completed
- NCT05283343 — Clinical Study of the Topcon Pachymeter TRK-3 to Evaluate Agreement and Precision · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06247072 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Topcon Corporation
- Last refreshed: 8 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06247072.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing